Business
Press Release May 14 2026
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.".
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled \"Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.\". View Attachment","length":384,"tagName":"div"}]